Imunon, Inc. (IMNN): Total Liabilities
$5.23M
As of 2025-12-31
$10.80M
As of 2026-06-30
-29.1%
3-year compound annual growth
-22.7%
5-year compound annual growth
-15.6%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.23M | -4.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $5.47M | -35.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $8.53M | -41.8% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $14.65M | -19.7% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $18.25M | -3.5% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $18.92M | -20.2% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $23.72M | -8.8% | 2021-03-19, Balance as of period end |
| 2018-12-31 | $25.99M | +24.9% | 2020-03-25, Balance as of period end |
| 2017-12-31 | $20.81M | -13.7% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $24.12M | -15.8% | 2018-03-27, Balance as of period end |
| 2015-12-31 | $28.64M | -15.4% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $33.87M | +139.4% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $14.15M | +5.6% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $13.40M | +107.5% | 2014-03-13, Balance as of period end |
| 2011-12-31 | $6.46M | -9.1% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $7.10M | n/a | 2012-03-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Imunon, Inc. (IMNN) | 2025-12-31 | $5.23M | -4.5% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $7.48M | +235.8% |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $487.7K | +87.2% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $1.77M | +456.8% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $28.89M | +7.5% |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $2.72M | +42.2% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $361.0K | n/m |
Compare IMNN, TTRX, ANEB, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗